KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Sales (2016 - 2026)

Pacific Biosciences Of California has reported Return on Sales over the past 16 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.03%, down 1.0%, while the annual FY2025 figure was 0.03%, 1.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.01% at Pacific Biosciences Of California, up from 0.01% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q4 2024 and troughed at 0.11% in Q1 2025.
  • A 5-year average of 0.02% and a median of 0.02% in 2024 define the central range for Return on Sales.
  • On a YoY basis, Return on Sales climbed as much as 4bps in 2025 and fell as far as -9bps in 2025.
  • Year by year, Return on Sales stood at 0.02% in 2021, then crashed by -60bps to 0.03% in 2022, then soared by 54bps to 0.01% in 2023, then skyrocketed by 104bps to 0.0% in 2024, then tumbled by -1596bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for PACB at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.